Biopharma Insights

FDA IND Approval of AI-derived Cancer Drug ISM3091 Marks a Milestone for Insilico Medicine

In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …

Continue ›››

Eli Lilly Collaborates with XtalPi to Harness AI in Drug Discovery

XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …

Continue ›››

Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology

Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) …

Continue ›››

Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials

Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …

Continue ›››

How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery

What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific …

Continue ›››

FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment

In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that …

Continue ›››

LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration

London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. …

Continue ›››

Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories

The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, …

Continue ›››

Advancing Cell-free Biocomputing

Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …

Continue ›››

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …

Continue ›››

The Power of STB CLOUD in Remote AI Drug Discovery

STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …

Continue ›››

AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning

The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …

Continue ›››